Trader's Diary - Week 22 February 2010

Relief as GDP is Revised Up

Trader's Diary - 26 February 2010 - 11:56 AM

There could have been red faces at the Treasury if the Q4 2009 GDP revision had been pushed below the zero level, but in the end a rise of 0.3% is what the Office for National Statistics have served up. This may be the reason that the FTSE 100 managed quite a significant jump from the overnight close under 5,280

RBS Turns The Corner

Trader's Diary - 25 February 2010 - 12:12 PM

There was only one story in the City today, that of RBS (RBS). A likely peak in impairments has cheered the market.

Banking Hopes

Trader's Diary - 24 February 2010 - 12:26 PM

Traders have high hopes for the forthcoming results of RBS (RBS) and Lloyds Banking (LLOY) later this week, and expect similar positives to the recent Barclays (BARC) results

Heartburn For Reckitt's

Trader's Diary - 23 February 2010 - 12:37 PM

A probe into Gaviscon by the OFT gives the Reckitts share price a case of heartburn.

GlaxoSmithkline Avandia Threat

Trader's Diary - 22 February 2010 - 12:39 PM

The FTSE100 and leading stocks continued the recent improvement, with banks and mining sectors supporting the gains this morning, in spite of the diabetes drug trouble development at drugs giant Glaxo.
Website design and build by Buzz Interactive

Copyright 2010 © Galvan Research and Trading Limited | CMA House, Newham Road, Truro, Cornwall, TR1 2SU | Call 01872 26 26 22